This paper is in the following e-collection/theme issue:

Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1570)

Published on in Vol 13, No 3 (2011): Jul-Sep

Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising

Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising

Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising

Authors of this article:

Bryan A Liang1, 2 ;   Timothy K Mackey2, 3 Author Orcid Image
Article Authors Cited by (94) Tweetations (11) Metrics

Journals

  1. Huhmann B, Limbu Y. Content and compliance of pharmaceutical social media marketing. Marketing Intelligence & Planning 2016;34(7):977 View
  2. Wong H, Field K, Shapiro J, McKendrick J, Gibbs P. Financial Incentives in Cancer Care and Impact on Prescribing Practice. Journal of Clinical Oncology 2013;31(23):2973 View
  3. Lopez C, Mosquera S, Taype-Rondán Á. Direct to consumer advertising on websites of Peruvian naturopathic pharmacies. European Journal of Hospital Pharmacy 2017;24(3):194 View
  4. Liang B, Mackey T, Lovett K. Suspect online sellers and contraceptive access. Contraception 2012;86(5):551 View
  5. Enyinda C, Ogbuehi A, Mbah C. Building pharmaceutical relationship marketing and social media impact. International Journal of Pharmaceutical and Healthcare Marketing 2018;12(2):198 View
  6. Xu W, Chiu I, Chen Y, Mukherjee T. Twitter hashtags for health: applying network and content analyses to understand the health knowledge sharing in a Twitter-based community of practice. Quality & Quantity 2015;49(4):1361 View
  7. Mackey T, Miner A, Cuomo R. Exploring the e-cigarette e-commerce marketplace: Identifying Internet e-cigarette marketing characteristics and regulatory gaps. Drug and Alcohol Dependence 2015;156:97 View
  8. Mackey T, Nayyar G. Digital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies. British Medical Bulletin 2016;118(1):110 View
  9. Fogel J, Herzog R. Direct-to-Consumer Prescription Medication Advertisements and Use of Different Types of Media. Journal of Electronic Commerce in Organizations 2020;18(4):51 View
  10. BINDHIM N, NAICKER S, FREEMAN B, MCGEECHAN K, TREVENA L. Apps Promoting Illicit Drugs—A Need for Tighter Regulation?. Journal of Consumer Health On the Internet 2014;18(1):31 View
  11. Kornfield R, Alexander G, Qato D, Kim Y, Hirsch J, Emery S. Trends in Exposure to Televised Prescription Drug Advertising, 2003–2011. American Journal of Preventive Medicine 2015;48(5):575 View
  12. Babar Z, Siraj A, Curley L. A review of DTCA techniques: Appraising their success and potential impact on medication users. Research in Social and Administrative Pharmacy 2018;14(3):218 View
  13. Limbu Y, McKinley C, Temperini V. A Longitudinal Examination of FDA Warning and Untitled Letters Issued to Pharmaceutical Companies for Violations in Drug Promotion Standards. Journal of Consumer Affairs 2019;53(1):3 View
  14. Mackey T. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(4):271 View
  15. Mackey T, Liang B, Strathdee S. Digital Social Media, Youth, and Nonmedical Use of Prescription Drugs: The Need for Reform. Journal of Medical Internet Research 2013;15(7):e143 View
  16. Mackey T, Yagi N, Liang B. Prescription drug coupons: Evolution and need for regulation in direct-to-consumer advertising. Research in Social and Administrative Pharmacy 2014;10(3):588 View
  17. Peiper N, Baumgartner P, Chew R, Hsieh Y, Bieler G, Bobashev G, Siege C, Zarkin G. Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California. Journal of Medical Internet Research 2017;19(7):e236 View
  18. Muncy J, Iyer R, Eastman J. Medical advertising on demand: A content analysis of YouTube direct-to-consumer pharmaceutical advertisements. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 2014;14(2-3):145 View
  19. Pinyopornpanish K, Jiraporncharoen W, Thaikla K, Yoonut K, Angkurawaranon C. Sedative and Analgesic Drugs Online: A Content Analysis of the Supply and Demand Information Available in Thailand. Substance Use & Misuse 2018;53(4):641 View
  20. Scott Rader C, Subhan Z, D. Lanier C, Brooksbank R, Yankah S, Spears K. CyberRx. International Journal of Pharmaceutical and Healthcare Marketing 2014;8(2):193 View
  21. Ball J, Manika D, Stout P. Causes and consequences of trust in direct-to-consumer prescription drug advertising. International Journal of Advertising 2016;35(2):216 View
  22. Noor S, Guo Y, Shah S, Nawaz M, Butt A. Research Synthesis and Thematic Analysis of Twitter Through Bibliometric Analysis. International Journal on Semantic Web and Information Systems 2020;16(3):88 View
  23. Zhou L, Zhang D, Yang C, Wang Y. Harnessing social media for health information management. Electronic Commerce Research and Applications 2018;27:139 View
  24. Wang W, Wang M. Effects of Sponsorship Disclosure on Perceived Integrity of Biased Recommendation Agents: Psychological Contract Violation and Knowledge-Based Trust Perspectives. Information Systems Research 2019;30(2):507 View
  25. Capurro D, Cole K, Echavarría M, Joe J, Neogi T, Turner A. The Use of Social Networking Sites for Public Health Practice and Research: A Systematic Review. Journal of Medical Internet Research 2014;16(3):e79 View
  26. Liang B, Mackey T. Vaccine shortages and suspect online pharmacy sellers. Vaccine 2012;30(2):105 View
  27. Mackey T, Cuomo R, Liang B. The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications. BMC Health Services Research 2015;15(1) View
  28. Mackey T, Schoenfeld V. Going “social” to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access. BMC Medicine 2016;14(1) View
  29. Wilson K, Keelan J. Social Media and the Empowering of Opponents of Medical Technologies: The Case of Anti-Vaccinationism. Journal of Medical Internet Research 2013;15(5):e103 View
  30. Mackey T, Liang B. Transparency in Physician-Industry Relationships. Pathology Case Reviews 2012;17(4):144 View
  31. Sullivan H, O’Donoghue A, Rupert D, Willoughby J, Aikin K. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites. Journal of Health Communication 2017;22(2):171 View
  32. Abrahams S. Milk and Social Media. Journal of Human Lactation 2012;28(3):400 View
  33. Carpentier F. Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(4):283 View
  34. Fogel J, Adnan M. Trust for pharmaceutical company direct-to-consumer prescription medication advertisements. Health Policy and Technology 2018;7(1):26 View
  35. Koteyko N, Hunt D, Gunter B. Expectations in the field of the Internet and health: an analysis of claims about social networking sites in clinical literature. Sociology of Health & Illness 2015;37(3):468 View
  36. Lau A, Gabarron E, Fernandez-Luque L, Armayones M. Social Media in Health — What are the Safety Concerns for Health Consumers?. Health Information Management Journal 2012;41(2):30 View
  37. Moch K. Ethical Crossroads: Expanded Access, Patient Advocacy, and the #SaveJosh Social Media Campaign. Medicine Access @ Point of Care 2017;1:maapoc.0000019 View
  38. Anderson A, Mackey T, Attaran A, Liang B. Mapping of Health Communication and Education Strategies Addressing the Public Health Dangers of Illicit Online Pharmacies. Journal of Health Communication 2016;21(4):397 View
  39. Mintzes B. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(5):329 View
  40. Kim H. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters. International Journal of Health Policy and Management 2015;4(12):813 View
  41. Mackey T, Kalyanam J, Katsuki T, Lanckriet G. Twitter-Based Detection of Illegal Online Sale of Prescription Opioid. American Journal of Public Health 2017;107(12):1910 View
  42. Mackey T, Liang B. Separating online piracy from counterfeit medicines: The need for policy reform and a call to action. Health Policy and Technology 2012;1(3):120 View
  43. Mackey T, Liang B. Global Reach of Direct-to-Consumer Advertising Using Social Media for Illicit Online Drug Sales. Journal of Medical Internet Research 2013;15(5):e105 View
  44. Adams C. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis. Journal of Medical Internet Research 2016;18(2):e33 View
  45. Liang B, Mackey T. Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics. Journal of Medical Internet Research 2012;14(1):e27 View
  46. Alkazemi M, Van Stee S. Electronic direct-to-consumer advertising of pharmaceuticals: an assessment of textual and visual content of websites. Health Education Research 2020;35(2):134 View
  47. Fogel J, Zhuk A. Direct-to-consumer prescription medication advertisements and obtaining prescriptions with or without a doctor’s prescription. Health Marketing Quarterly 2019;36(3):220 View
  48. Mackey T, Liang B. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Globalization and Health 2013;9(1):45 View
  49. Liang B, Mackey T, Lovett K. Illegal “No Prescription” Internet Access to Narrow Therapeutic Index Drugs. Clinical Therapeutics 2013;35(5):694 View
  50. Grajales III F, Sheps S, Ho K, Novak-Lauscher H, Eysenbach G. Social Media: A Review and Tutorial of Applications in Medicine and Health Care. Journal of Medical Internet Research 2014;16(2):e13 View
  51. Tyrawski J, DeAndrea D. Pharmaceutical Companies and Their Drugs on Social Media: A Content Analysis of Drug Information on Popular Social Media Sites. Journal of Medical Internet Research 2015;17(6):e130 View
  52. Mackey T, Liang B. Oncology and the Internet: Regulatory Failure and Reform. Journal of Oncology Practice 2012;8(6):341 View
  53. Song Q, Ung C, Tang D, Hu H. The Use of Microblog “Weibo” by Chinese Patent Medicine Companies in China. Therapeutic Innovation & Regulatory Science 2019;53(4):490 View
  54. Liang B, Mackey T. Stem Cells, Dot-Com. Science Translational Medicine 2012;4(151) View
  55. Sullivan H, Campbell M. Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration. Journal of Health Communication 2015;20(12):1391 View
  56. Mackey T, Aung P, Liang B. Illicit Internet availability of drugs subject to recall and patient safety consequences. International Journal of Clinical Pharmacy 2015;37(6):1076 View
  57. Williams S, Terras M, Warwick C. How Twitter Is Studied in the Medical Professions: A Classification of Twitter Papers Indexed in PubMed. Medicine 2.0 2013;2(2):e2 View
  58. Southwell B, Rupert D. Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(3):211 View
  59. Sullivan H, Aikin K, Chung-Davies E, Wade M, Yao L. Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration. PLOS ONE 2016;11(5):e0155035 View
  60. Wang W, Xu J, Wang M. Effects of Recommendation Neutrality and Sponsorship Disclosure on Trust vs. Distrust in Online Recommendation Agents: Moderating Role of Explanations for Organic Recommendations. Management Science 2018;64(11):5198 View
  61. Zhao H, Muthupandi S, Kumara S. Managing Illicit Online Pharmacies: Web Analytics and Predictive Models Study. Journal of Medical Internet Research 2020;22(8):e17239 View
  62. Mackey T, Eysenbach G, Liang B, Kohler J, Geissbuhler A, Attaran A. A call for a moratorium on the .health generic top-level domain: preventing the commercialization and exclusive control of online health information. Globalization and Health 2014;10(1) View
  63. Salimian P, Chunara R, Weitzman E. Averting the Perfect Storm: Addressing Youth Substance Use Risk From Social Media Use. Pediatric Annals 2014;43(10) View
  64. Sullivan H, O’Donoghue A, Rupert D, Willoughby J, Amoozegar J, Aikin K. Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study. Journal of Health Communication 2016;21(11):1198 View
  65. Ben Said Y, Bragazzi N, Pyatigorskaya N. Prevalence and Perceived Effectiveness of Pharmaceutical Digital Marketing among Community Pharmacies in Saudi Arabia: A Cross-Sectional Questionnaire-Based Survey. Pharmacy 2020;8(1):9 View
  66. Alkhalidi D, Jamshed S, Elkalmi R, Baig M, Aslam A, Hassali M. General Public Views, Attitudes, and Experiences toward Drug Safety in Dubai, United Arab Emirates: A Qualitative Approach. Pharmacy 2019;7(1):19 View
  67. Gibson S. Regulating Direct-to-Consumer Advertising of Prescription Drugs in the Digital Age. Laws 2014;3(3):410 View
  68. Daubner J, Arshaad M, Henseler C, Hescheler J, Ehninger D, Broich K, Rawashdeh O, Papazoglou A, Weiergräber M, Mangel S. Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives. Neural Plasticity 2021;2021:1 View
  69. Amalia B, Kapoor S, Sharma R, Fu M, Fernández E, Rana J. Online sales compliance with the electronic cigarettes ban in India: a content analysis. International Journal of Public Health 2020;65(8):1497 View
  70. Kostagiolas P, Koumbouli M, Theodorou P, Stamou S. Investigation of the Information-Seeking Behavior of Hospitalized Patients at the General Hospital of Corfu. Journal of Hospital Librarianship 2021;21(1):36 View
  71. Darmawan I, Huh J. The Effects of Message Type and Sponsorship Disclosure in Influencer Marketing of Prescription Drugs. Journal of Global Marketing 2022;35(1):21 View
  72. Fatoki T. Biomarketing: Understanding Brand Perception through Biological Process, and User-Friendly Materials and Platforms. Scientific Bulletin 2021;26(1):32 View
  73. Ahmed J, Modica de Mohac L, Mackey T, Raimi-Abraham B. A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives. The Journal of Medicine Access 2022;6:239920262210745 View
  74. Alhabash S, Dong Y, Moureaud C, Muraro I, Hertig J. Effects of Fear and Humor Appeals in Public Service Announcements (PSAs) on Intentions to Purchase Medications via Social Media. International Journal of Environmental Research and Public Health 2022;19(19):12340 View
  75. Missoni E. Determinanti globali della salute e (in)sostenibilità dell'obiettivo di copertura sanitaria universale. WELFARE E ERGONOMIA 2019;(1):11 View
  76. Suryanarayanan A. The Use of Direct-to-Consumer (DTC) Pharmaceutical Advertisements in Televised and Print Formats as a Teaching Tool in a Pharmacy Curriculum. Pharmacy 2021;9(3):149 View
  77. Mukherjee S, Kumar J, Pareek S, Jha A. Analysis of Information About Medicines Available on Facebook. International Journal of e-Collaboration 2021;18(1):1 View
  78. Fogel J, Shraybman-Buynova J. Direct-to-consumer prescription medication advertisements on social media: The role of social factors. Health Marketing Quarterly 2023;40(2):190 View
  79. Moureaud C, Hertig J, Dong Y, Muraro I, Alhabash S. Purchase of prescription medicines via social media: A survey-based study of prevalence, risk perceptions, and motivations. Health Policy 2021;125(11):1421 View
  80. Andrew Leynes P, Upadhyay T. Context dissociations of the FN400 and N400 are evidence for recognition based on relative or absolute familiarity. Brain and Cognition 2022;162:105903 View
  81. Limbu Y, Huhmann B. Illicit Online Pharmacies: A Scoping Review. International Journal of Environmental Research and Public Health 2023;20(9):5748 View
  82. Verma S, Tiwari R, Singh L. Integrating technology and trust: Trailblazing role of AI in reframing pharmaceutical digital outreach. Intelligent Pharmacy 2024;2(3):435 View

Books/Policy Documents

  1. Hall A, Antonopoulos G. Fake Meds Online. View
  2. Mackey T. Fetal Stem Cells in Regenerative Medicine. View
  3. An Z, McLaughlin M, Hou J, Nam Y, Hu C, Park M, Meng J. Social Computing and Social Media. View
  4. Adi A, Grigore G. Corporate Social Responsibility in the Digital Age. View
  5. Fogel J, Herzog R. Research Anthology on Social Media Advertising and Building Consumer Relationships. View
  6. Liu Q, Gupta S. Innovation and Marketing in the Pharmaceutical Industry. View
  7. Mukherjee S, Sarkar A, Kumar J, Singh A, Jha A. Accelerating Strategic Changes for Digital Transformation in the Healthcare Industry. View
  8. Jotterand F, Ienca M, Wangmo T, Elger B, Robillard J, Feng T. Intelligent Assistive Technologies for Dementia. View